142 related articles for article (PubMed ID: 34969755)
1. Clinicopathological Analysis of Non-B Non-C Hepatocellular Carcinoma Focusing on Cellular Proliferation.
Mizuochi S; Akiba J; Kondo R; Kusano H; Shioga T; Kondo K; Tsutsui K; Nakayama M; Ogasawara S; Naito Y; Nakashima O; Yano H
Anticancer Res; 2022 Jan; 42(1):449-457. PubMed ID: 34969755
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
[TBL] [Abstract][Full Text] [Related]
3. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
4. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
6. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
7. Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma.
Shindo K; Maekawa S; Komatsu N; Tatsumi A; Miura M; Sato M; Suzuki Y; Matsuda S; Muraoka M; Amemiya F; Fukasawa M; Yamaguchi T; Nakayama Y; Uetake T; Inoue T; Sakamoto M; Sato T; Enomoto N
Mediators Inflamm; 2015; 2015():687484. PubMed ID: 26494948
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
[TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome.
Imura S; Shimada M; Utsunomiya T; Morine Y; Ikemoto T; Mori H; Arakawa Y; Kanamoto M; Iwahashi S; Miyake H
Hepatogastroenterology; 2014; 61(129):129-35. PubMed ID: 24895808
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus.
Noguchi K; Nakashima O; Nakashima Y; Shiota K; Nawata H; Kojiro M
Int J Mol Med; 2000 Dec; 6(6):661-5. PubMed ID: 11078825
[TBL] [Abstract][Full Text] [Related]
13. Disparity of Hepatocellular Carcinoma in Tumor Microenvironment-Related Genes and Infiltrating Immune Cells between Asian and Non-Asian Populations.
Huang LH; Hsieh TM; Huang CY; Liu YW; Wu SC; Chien PC; Hsieh CH
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440448
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
[TBL] [Abstract][Full Text] [Related]
15. A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.
Kusakabe A; Tanaka Y; Orito E; Sugauchi F; Kurbanov F; Sakamoto T; Shinkai N; Hirashima N; Hasegawa I; Ohno T; Ueda R; Mizokami M
J Gastroenterol; 2007 Apr; 42(4):298-305. PubMed ID: 17464459
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis.
Yu B; Zhi X; Li Q; Li T; Chen Z
BMC Gastroenterol; 2023 Aug; 23(1):289. PubMed ID: 37612653
[TBL] [Abstract][Full Text] [Related]
17. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
Nagaoki Y; Hyogo H; Ando Y; Kosaka Y; Uchikawa S; Nishida Y; Teraoka Y; Morio K; Fujino H; Ono A; Nakahara T; Murakami E; Yamauchi M; Okamoto W; Kawaoka T; Tsuge M; Hiramatsu A; Miki D; Imamura M; Takahashi S; Chayama K; Aikata H
BMC Gastroenterol; 2021 Jul; 21(1):306. PubMed ID: 34332532
[TBL] [Abstract][Full Text] [Related]
18. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.
Huo TI; Wu JC; Hsia CY; Chau GY; Lui WY; Huang YH; Lee PC; Chang FY; Lee SD
World J Surg; 2004 Aug; 28(8):787-91. PubMed ID: 15457359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
